Asian Stocks Rise as Anthropic IPO Revives AI Optimism
Asian stocks climbed after Anthropic’s IPO filing renewed enthusiasm for AI companies, but earnings and central-bank decisions will determine whether the rally lasts.
FTC and 20 States Sue Dollar General Over Pricing
The FTC and 20 states accuse Dollar General of charging some customers more at checkout than prices displayed on store shelves. The allegations remain unproven.
United Flight Turns Around After Alleged Hijacking Comment
A United Airlines flight reportedly turned around after a passenger allegedly made comments about hijacking, including the phrase “Crash ur row only.”
JetBlue Shares Gain Relief After Third-Quarter Results
JetBlue’s third-quarter results and 2027 outlook lifted investor sentiment, but creditor concerns and restructuring risks mean the airline’s recovery remains unproven.
Anthropic IPO Could Be One of the Largest Ever
Anthropic has reportedly filed for an IPO that could rank among the largest ever, even as CEO Dario Amodei warns about AI risks to humanity.
Microsoft Offers Buyouts to Up to 60,000, Including Xbox Staff
Microsoft has reportedly offered voluntary exit packages to up to 60,000 employees, including Xbox-related staff. The final workforce impact remains unconfirmed.
Broadcom Reportedly Arranges $63B Anthropic Chip Deal
Broadcom is reportedly helping arrange up to $63 billion in financing for AI chips and infrastructure intended for Anthropic, with banks and Blackstone involved.
Dollar General Sued Over Alleged Pricing Discrepancies
The FTC and 20 states allege that some Dollar General shoppers paid more at checkout than prices displayed in stores. The case remains unresolved.
Anthropic IPO Updates and $542 Billion Data-Center Claim
Anthropic has not confirmed an IPO, listing date, exchange, or price range. The reported $542 billion data-center figure remains an unverified forecast.
Microsoft Buyout Plan for 60,000 Workers Explained
Microsoft is reportedly considering voluntary buyouts involving approximately 60,000 employees as part of a broader cost-cutting and efficiency effort. Key details remain unconfirmed.
Stock Market Today: Dow, S&P 500, and Nasdaq Rally
The Dow, S&P 500, and Nasdaq rose as investors assessed Anthropic’s reported IPO filing and prepared for a busy week of technology earnings.
JetBlue Creditors Hire Advisers as Financial Concerns Grow
JetBlue creditors reportedly hired financial and restructuring advisers, signaling concern about debt and liquidity but not confirming bankruptcy or changes to customer benefits.
Five Charts Explain US Inflation Under Trump
Inflation has slowed since its 2021–2022 peak, but prices remain much higher than before the pandemic. Five charts explain the difference.
Meta’s Reported $35 Billion AI Stock Offering
Meta’s reported $35 billion stock offering could fund AI infrastructure, research, and talent, but dilution and conflicting reports require official confirmation.
Global Shares Rise as Oil Prices Fall More Than 1%
Global shares mostly advanced after Wall Street declined, while oil prices fell more than 1%. The rebound remained uneven, with South Korea’s Kospi suffering a sharp semiconductor-led sell-off.
SpaceX’s Reported $40B GPU Financing Explained
Reports link SpaceX to a $40 billion AI infrastructure transaction as Elon Musk warns that intense competition could consolidate the AI cloud market.
SpaceX’s Reported $40 Billion AI Chip Debt Deal
Elon Musk reportedly said SpaceX closed a $40 billion debt deal for AI chips, but lenders, terms, drawdown status, and deployment plans remain unknown.
Asian Stocks Wary as Brent Oil Falls From Six-Month High
Asian stocks traded cautiously as investors weighed renewed trade-war concerns against relief from Brent crude retreating from a six-month high.
Why Japanese Companies Compensate Cyberattack Victims
Japanese companies are compensating users after cyberattacks disrupt services, expose data, and spread financial costs across connected business networks.
Personalized Melanoma Vaccine Cuts Risk by 42%
A reported trial found that a personalized mRNA melanoma vaccine reduced the combined risk of recurrence or death by 42%, but key evidence remains pending.